Informations générales (source: ClinicalTrials.gov)

NCT05957276 Active, sans recrutement
Global Patient Registry of Inherited Retinal Disease
Observational
  • Rétinopathies
Janssen Research & Development, LLC (Voir sur ClinicalTrials)
août 2023
juillet 2026
02 décembre 2025
The purpose of this study is to better understand the natural history of Inherited Retinal Disease (IRD) and help inform patient management.

Etablissements

Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Hopitaux universitaires de Strasbourg - 67091 - Srasbourg - France En recrutement Contact (sur clinicalTrials)

Critères

Tous


For Participant Selection:

- Participant has any clinically documented sign(s) and/or symptom(s) consistent with
an Inherited Retinal Disease (IRD), or asymptomatic with documented retinal changes
detected by imaging or electrophysiology

- Participant has documented genetic variant(s) (known pathogenic, likely pathogenic,
or variants of uncertain significance) in relevant genes for any of the following
IRDs: X-Linked Retinitis Pigmentosa (XLRP) and/or Achromatopsia (ACHM)

- Participant or legally acceptable representative has provided informed consent (and
participant assent, when applicable) in accordance with local requirements

- Participant is able to have relevant visual and/or retinal assessments performed

For Caregiver Selection:

- Caregiver has consent from the associated participant to participate in the study,
or participant assent and consent from their legally acceptable representative

- Male or female aged greater than or equal to (>=)18 years

- Identified by an enrolled participant (or their legally acceptable representative*)
as a primary caregiver

- Caregiver has provided informed consent in accordance with local requirements

Exclusion Criteria:


For Participant Selection:

- Participant has received a treatment in an IRD-related interventional trial, or is
being screened for an IRD-related interventional trial

For Caregiver Selection:

- Caregiver has an IRD diagnosis and presents with symptoms (visual impairment)